Who has invested in Aerovate Therapeutics?

Sofinnova Investments, Atlas Venture are named among the investors backing Aerovate Therapeutics.

Aerovate Therapeutics Funding: $76M Raised, Series A (2020)

Aerovate Therapeutics funding overview

Aerovate Therapeutics is based in Boston, MA. Aerovate Therapeutics has raised $76M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in August 2020. The round record for Aerovate Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Sofinnova Investments, Atlas Venture. 2 distinct backers are named across the disclosed rounds.

Aerovate Therapeutics at a glance

Total raised: $76M
Latest round: Series A
Latest round date: August 2020
Headquarters: Boston, MA
Notable investors: Sofinnova Investments, Atlas Venture

Frequently asked about Aerovate Therapeutics funding

How much has Aerovate Therapeutics raised?: Aerovate Therapeutics has raised $76M in total disclosed funding across the rounds on record.
Who has invested in Aerovate Therapeutics?: Sofinnova Investments, Atlas Venture are named among the investors backing Aerovate Therapeutics.
What was the latest Aerovate Therapeutics funding round?: The most recent disclosed round is a Series A, announced in August 2020.
Where is Aerovate Therapeutics based?: Aerovate Therapeutics is based in Boston, MA.
When did Aerovate Therapeutics last raise?: The last disclosed Aerovate Therapeutics round closed in August 2020 at Series A.

Aerovate Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Boston below to benchmark round size and investor mix.

Aerovate Therapeutics Funding: $76M Raised, Series A (2020)

Aerovate Therapeutics funding overview

Aerovate Therapeutics at a glance

Frequently asked about Aerovate Therapeutics funding

Companies related to Aerovate Therapeutics (36)

Browse related funding lists (7)